Beauty Health Co

For the period ended Mar 31, 2024. Filed May 9, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 9, 2024

SKIN$15.94-4.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets (Unaudited)

Item 1. Financial Statements.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except for share amounts)

	March 31, 2024	December 31, 2023
ASSETS
Current assets:
Cash, cash equivalents, and restricted cash	$444,634	$523,025
Accounts receivable, net of allowances for estimated credit losses of $7,228 and $6,604 at March 31, 2024 and December 31, 2023, respectively	47,666	54,697
Inventories	95,721	91,321
Income tax receivable	1,204	332
Prepaid expenses and other current assets	25,599	28,877
Total current assets	614,824	698,252
Property and equipment, net	12,048	14,226
Right-of-use assets, net	16,383	12,120
Intangible assets, net	58,405	62,123
Goodwill	125,365	125,818
Deferred income tax assets, net	1,932	531
Other assets	15,784	16,043
TOTAL ASSETS	$844,741	$929,113
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$37,312	$44,768
Accrued payroll-related expenses	15,456	22,028
Syndeo Program reserves	8,314	21,009
Lease liabilities, current	4,648	4,598
Income tax payable	3,443	2,759
Other accrued expenses	24,395	19,846
Total current liabilities	93,568	115,008
Lease liabilities, non-current	13,688	9,319
Deferred income tax liabilities, net	1,068	702
Warrant liabilities	5,019	3,555
Convertible senior notes, net	665,486	738,372
Other long-term liabilities	2,617	2,767
Total liabilities	781,446	869,723
Commitments (Note 10)
Stockholders’ equity:
Class A Common Stock, $0.0001 par value; 320,000,000 shares authorized; 123,453,419 and 122,899,002 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	12	12
Additional paid-in capital	546,912	541,281
Accumulated other comprehensive loss	(4,083)	(3,036)
Accumulated deficit	(479,546)	(478,867)
Total stockholders’ equity	63,295	59,390
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$844,741	$929,113

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.